MARKETS

BSE Prices delayed by 5 minutes... Prices as on Jun 25, 2018 - 3:54PM   ABB India 1186.95 [ -2.17% ]ACC 1311 [ 1.32% ]Ambuja Cements Ltd. 206.8 [ 1.00% ]Asian Paints Ltd. 1254.05 [ -1.12% ]Axis Bank Ltd. 515.15 [ -1.81% ]Bajaj Auto Ltd. 2805 [ -0.91% ]Bank of Baroda 116.8 [ -4.07% ]Bharti Airtel 371 [ -0.96% ]Bharat Heavy Ele 73.35 [ -2.20% ]Bharat Petroleum 412.65 [ -3.16% ]Britannia Ind. 5975.4 [ 0.18% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 610 [ -0.65% ]Coal India Ltd. 259.05 [ -2.28% ]Colgate Palm. 1182 [ 0.20% ]Dabur India 383.95 [ -0.40% ]DLF Ltd. 196.6 [ -1.97% ]Dr. Reddy's Labs 2290.1 [ -1.92% ]GAIL (India) Ltd. 338.55 [ -0.47% ]Grasim Inds. 1006.95 [ -0.68% ]HCL Technologies 909.85 [ 0.37% ]HDFC 1893.65 [ -0.46% ]HDFC Bank 2093.95 [ 0.58% ]Hero MotoCorp 3575.6 [ -1.77% ]Hindustan Unilever L 1614.25 [ 0.42% ]Hindalco Indus. 218.95 [ -1.53% ]ICICI Bank 289.45 [ -3.79% ]IDFC L 48.1 [ -0.41% ]Indian Hotels Co 132.65 [ -1.89% ]IndusInd Bank 1967 [ 0.64% ]Infosys 1272.3 [ 2.07% ]ITC Ltd. 262.55 [ -0.98% ]Jindal St & Pwr 225.95 [ -2.04% ]Kotak Mahindra Bank 1329.45 [ 0.70% ]L&T 1269 [ -2.05% ]Lupin Ltd. 914.05 [ 1.01% ]Mahi. & Mahi 906.85 [ -0.14% ]Maruti Suzuki India 8792.1 [ -1.10% ]MTNL 17.1 [ -3.93% ]Nestle India 9925 [ 0.55% ]NIIT Ltd. 96.35 [ 0.10% ]NMDC Ltd. 108.25 [ -0.87% ]NTPC 155 [ -1.21% ]ONGC 156.7 [ -1.72% ]Punj. NationlBak 79.7 [ -2.98% ]Power Grid Corpo 195 [ -1.44% ]Reliance Inds. 1003.55 [ -0.86% ]SBI 268.3 [ -1.81% ]Vedanta 230.25 [ 0.70% ]Shipping Corpn. 60.55 [ -1.14% ]Sun Pharma. 572.15 [ -0.72% ]Tata Chemicals 716.05 [ -0.48% ]Tata Global Beverage 263.7 [ 0.63% ]Tata Motors Ltd. 289.85 [ -5.94% ]Tata Steel 558.5 [ -0.35% ]Tata Power Co. 76.1 [ 0.00% ]Tata Consultancy 1820.45 [ 0.48% ]Tech Mahindra Ltd. 695.7 [ 0.70% ]UltraTech Cement 3750.4 [ 2.83% ]United Spirits 672.7 [ -1.07% ]Wipro Ltd 257.45 [ -0.19% ]Zee Entertainment En 559.25 [ -1.12% ]

News Details

You can view in detail.
Lupin launches Tobramycin Inhalation Solution in US 14/06/2018 09:25

Pharma major Lupin has said that it has launched Tobramycin Inhalation Solution USP, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Tobramycin Inhalation Solution USP, 300 mg/5 ml is the generic equivalent of Novartis Pharmaceuticals Corporation's Tobis 300 mg/5 ml.

It is indicated for the management of cystic fibrosis patients with P. aeruginosa. Tobramycin Inhalation Solution USP, 300 mg/5 ml had annual sales of approximately USD 99 million in the US (IQVIA MAT April 2018).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.

Meanwhile, shares of the company were trading at Rs 875.95 apiece up 0.73 per cent from the previous close at 09:25 hrs on BSE.

LOAD MORE